E. Krill-jackson

A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.

C. Obasaju, J. Hainsworth, A. Brufsky, 2011, Clinical breast cancer.

Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.

S. Zeichner, A. L. Ruiz, G. Suciu, 2014, Asian Pacific journal of cancer prevention : APJCP.

The faces of mast cell disease: bone marrow infiltrates in 3 patients with systemic mastocytosis.

Antonio E Martinez, J. Hyde, A. Blaustein, 2005, Annals of diagnostic pathology.

A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer

S. Franco, C. Vogel, E. Tan-chiu, 2011 .

The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas

Akbari, S. Narod, J. Hurley, 2014, Clinical genetics.

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas

S. Narod, J. Hurley, R. Royer, 2010, Breast Cancer Research and Treatment.

High Frequency of BRCA1 Founder Mutations in the Bahamas.

S. Narod, J. Hurley, R. Royer, 2009 .